Published in Clin Exp Med on August 15, 2013
Methotrexate-related response on human peripheral blood mononuclear cells may be modulated by the Ala16Val-SOD2 gene polymorphism. PLoS One (2014) 0.86
The possibilities and principles of methotrexate treatment of psoriasis - the updated knowledge. Postepy Dermatol Alergol (2014) 0.76
Plasma total antioxidant capacity and peroxidation biomarkers in psoriasis. J Biomed Sci (2016) 0.75
Inhibition of inflammatory and proliferative responses of human keratinocytes exposed to the sesquiterpene lactones dehydrocostuslactone and costunolide. PLoS One (2014) 0.75
Hepatocellular carcinoma-targeted drug discovery through image-based phenotypic screening in co-cultures of HCC cells with hepatocytes. BMC Cancer (2016) 0.75
Effects of Pomegranate (Punica Granatum L.) Seed and Peel Methanolic Extracts on Oxidative Stress and Lipid Profile Changes Induced by Methotrexate in Rats. Adv Pharm Bull (2017) 0.75
Pharmacogenetic markers to predict the clinical response to methotrexate in south Indian Tamil patients with psoriasis. Eur J Clin Pharmacol (2017) 0.75
Analysis of nitrate, nitrite, and [15N]nitrate in biological fluids. Anal Biochem (1982) 27.26
Malondialdehyde determination as index of lipid peroxidation. Methods Enzymol (1990) 6.65
Role of reactive oxygen species (ROS) in apoptosis induction. Apoptosis (2000) 5.78
Pathogenesis and clinical features of psoriasis. Lancet (2007) 5.01
A novel method for measuring antioxidant capacity and its application to monitoring the antioxidant status in premature neonates. Clin Sci (Lond) (1993) 4.25
A simple method for determination of serum catalase activity and revision of reference range. Clin Chim Acta (1991) 3.27
Oxidative stress in the pathogenesis of skin disease. J Invest Dermatol (2006) 3.16
Suppression of apoptosis by nitric oxide via inhibition of interleukin-1beta-converting enzyme (ICE)-like and cysteine protease protein (CPP)-32-like proteases. J Exp Med (1997) 2.76
Methotrexate versus cyclosporine in moderate-to-severe chronic plaque psoriasis. N Engl J Med (2003) 2.12
The pathogenesis of psoriasis: immunological facts and speculations. Immunol Today (1999) 2.08
Antioxidant activity, lipid peroxidation and skin diseases. What's new. J Eur Acad Dermatol Venereol (2003) 1.67
Epidermal keratinocyte expression of inducible nitric oxide synthase in skin lesions of psoriasis vulgaris. Lancet (1994) 1.64
Increased expression of inducible nitric oxide synthase in psoriatic skin and cytokine-stimulated cultured keratinocytes. Br J Dermatol (1996) 1.60
Programmed cell death of keratinocytes in infliximab-treated plaque-type psoriasis. Br J Dermatol (2006) 1.44
Methotrexate reduces inflammatory cell numbers, expression of monokines and of adhesion molecules in synovial tissue of patients with rheumatoid arthritis. Br J Rheumatol (1998) 1.38
Rapid kinetics of tBid-induced cytochrome c and Smac/DIABLO release and mitochondrial depolarization. J Biol Chem (2001) 1.36
Nitric oxide function in the skin. Nitric Oxide (2004) 1.36
Nitrate determination in biological fluids by an enzymatic one-step assay with nitrate reductase. Clin Chem (1995) 1.33
UVB-induced senescence in human keratinocytes requires a functional insulin-like growth factor-1 receptor and p53. Mol Biol Cell (2008) 1.26
Detection of nitric oxide and nitric oxide synthases in psoriasis. Arch Dermatol Res (1998) 1.25
Methotrexate suppresses NF-kappaB activation through inhibition of IkappaBalpha phosphorylation and degradation. J Immunol (2001) 1.24
The pharmacology of methotrexate. J Am Acad Dermatol (1991) 1.13
Induction of macrophage nitric oxide production by interferon-gamma and tumor necrosis factor-alpha is enhanced by interleukin-10. Eur J Immunol (1993) 1.12
Protein expression of TNF-alpha in psoriatic skin is regulated at a posttranscriptional level by MAPK-activated protein kinase 2. J Immunol (2006) 1.08
Methotrexate in psoriasis: revised guidelines. J Am Acad Dermatol (1988) 1.08
Oxidative stress and its role in skin disease. Antioxid Redox Signal (2002) 1.06
The anti-inflammatory actions of methotrexate are critically dependent upon the production of reactive oxygen species. Br J Pharmacol (2003) 1.06
Keratin 6 expression correlates to areas of squamous differentiation in multiple independent isolates of As(+3)-induced bladder cancer. J Appl Toxicol (2010) 1.03
Evaluation of the atherogenic tendency of lipids and lipoprotein content and their relationships with oxidant-antioxidant system in patients with psoriasis. Clin Chim Acta (2003) 0.98
Oxidant / antioxidant status in patients with psoriasis. Yonsei Med J (2003) 0.95
Increased sensitivity to apoptosis induced by methotrexate is mediated by JNK. Arthritis Rheum (2011) 0.92
The role of oxidants and antioxidants in psoriasis. J Eur Acad Dermatol Venereol (2003) 0.91
Evaluation of the anti-proliferative properties of selected psoriasis-treating Chinese medicines on cultured HaCaT cells. J Ethnopharmacol (2006) 0.90
Methotrexate induces apoptotic cell death in human keratinocytes. Arch Dermatol Res (1998) 0.89
A comprehensive review of biomarkers in psoriasis. Clin Exp Dermatol (2009) 0.89
Apoptosis in established and healing psoriasis. Dermatology (2000) 0.89
Psoriasis--pathophysiology, conventional, and alternative approaches to treatment. Altern Med Rev (2007) 0.88
Superoxide dismutase in psoriasis, squamous cell carcinoma and basal cell epithelioma: an immunohistochemical study. Br J Dermatol (1991) 0.85
A deficient function of the antioxidative system of the organism as an aetiopathogenetic factor in psoriasis. Med Hypotheses (1991) 0.85
Methotrexate inhibition of inducible nitric oxide synthase in murine lung epithelial cells in vitro. Am J Respir Cell Mol Biol (1998) 0.84
Erythrocyte membrane fluidity changes in psoriasis: an EPR study. J Dermatol Sci (2001) 0.84
Apoptosis in psoriatic epidermis. J Cutan Pathol (2008) 0.84
Nitric oxide, skin growth and differentiation: more questions than answers? Clin Exp Dermatol (1999) 0.83
Use of methotrexate in patients with psoriasis. Clin Exp Rheumatol (2010) 0.81
Effect of fish oil supplementation on erythrocyte lipid pattern, malondialdehyde production and glutathione-peroxidase activity in psoriasis. Clin Chim Acta (1989) 0.81
Ultraviolet-B irradiation decreases IFN-gamma and increases IL-4 expression in psoriatic lesional skin in situ and in cultured dermal T cells derived from these lesions. Exp Dermatol (2003) 0.81
The relationship between nitric oxide production and activity of the disease in patients with psoriasis. Arch Dermatol (1997) 0.81
Methotrexate suppresses nitric oxide production ex vivo in macrophages from rats with adjuvant-induced arthritis. Res Exp Med (Berl) (1997) 0.80
Apoptosis in physiological and pathological skin: implications for therapy. Curr Mol Med (2006) 0.79
Increased superoxide anion production in dermal fibroblasts of psoriatic patients. Skin Pharmacol (1993) 0.79
Oxidative stress in keratinocytes as an etiopathogenetic factor of psoriasis. Bull Exp Biol Med (2000) 0.79
Clinical and biochemical effects of coenzyme Q(10), vitamin E, and selenium supplementation to psoriasis patients. Nutrition (2008) 0.78
A study of serum nitric oxide levels in psoriasis. Indian J Dermatol Venereol Leprol (2006) 0.78
[Psoriasis. Pathogenesis]. Presse Med (1999) 0.77
Woolly hair nevus: a rare entity. Int J Trichology (2012) 0.98
A giant variant of acquired reactive perforating collagenosis associated with hydronephrosis: successful treatment with allopurinol. Int J Dermatol (2009) 0.95
Injection of isolated mitochondria during early reperfusion for cardioprotection. Am J Physiol Heart Circ Physiol (2008) 0.94
Role of sudarshan kriya and pranayam on lipid profile and blood cell parameters during exam stress: A randomized controlled trial. Int J Yoga (2012) 0.84
Serum interleukin-6 levels in response to methotrexate treatment in psoriatic patients. Clin Chim Acta (2012) 0.83
Psychological well-being in medical students during exam stress-influence of short-term practice of mind sound technology. Indian J Med Sci (2010) 0.81
Downregulation of involucrin in psoriatic lesions following therapy with propylthiouracil, an anti-thyroid thioureylene: immunohistochemistry and gene expression analysis. Int J Dermatol (2014) 0.80
Clinical efficacy of propylthiouracil and its influence on prolactin in psoriatic patients. Clin Biochem (2011) 0.78
Squamous cell carcinoma of penis with bullous pemphigoid masquerading as lymphogranuloma venereum. Indian J Sex Transm Dis (2013) 0.75
Therapeutic efficacy and safety of propylthiouracil in psoriasis: an open-label study. Indian J Dermatol Venereol Leprol (2011) 0.75
Impact of propylthiouracil on quality of life in psoriasis patients. Indian J Med Sci (2011) 0.75
Bullous congenital ichthyosiform erythroderma with rickets: a rare association. Int J Dermatol (2013) 0.75